As of the latest SEC filings, Travere Therapeutics, Inc. (TVTX) is held by 294 institutional funds. The largest fund shareholder is Strategic Advisers Fidelity U.S. Total Stock Fund (FCTDX), holding an estimated $101,537,636.13 in market value, representing 0.05% of its portfolio.
Funds holding Travere Therapeutics, Inc. (TVTX)
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- TVTX
- CIK:
- 0001438533
| Fund | Type | Manager | Weight | Market Value | Shares |
Report Date
|
Filing Date
|
|---|---|---|---|---|---|---|---|
|
FCTDX
Strategic Advisers Fidelity U.S. Total Stock Fund
|
MF | Fidelity | 0.05% | $101,537,636.13 | 3,408,447 | Feb 28, 2026 | Apr 24, 2026 |
|
VTI
VANGUARD TOTAL STOCK MARKET INDEX FUND
|
ETF | Vanguard | 0.00% | $87,625,871.83 | 2,949,373 | Mar 31, 2026 | May 28, 2026 |
|
XBI
State Street(R) SPDR(R) S&P(R) Biotech ETF
|
ETF | State Street (SPDR) | 1.14% | $85,065,434.32 | 2,863,192 | Mar 31, 2026 | May 28, 2026 |
|
DCCIX
Nomura Small Cap Core Fund
|
MF | Independent / Boutique | 1.14% | $65,307,484.98 | 2,192,262 | Feb 27, 2026 | Apr 23, 2026 |
|
IWM
iShares Russell 2000 ETF
|
ETF | BlackRock / iShares | 0.08% | $59,935,706.18 | 2,017,358 | Mar 31, 2026 | May 28, 2026 |
|
VEXPX
VANGUARD EXPLORER FUND
|
MF | Vanguard | 0.24% | $51,780,348.36 | 1,229,353 | Apr 30, 2026 | Jun 26, 2026 |
|
JAGLX
Janus Henderson Global Life Sciences Fund
|
MF | Independent / Boutique | 0.82% | $42,549,592.44 | 1,432,164 | Mar 31, 2026 | May 29, 2026 |
|
FBCHX
Fidelity Blue Chip Growth Fund
|
MF | Fidelity | 0.04% | $38,494,436.76 | 913,923 | Apr 30, 2026 | Jun 26, 2026 |
|
FSSNX
Fidelity Small Cap Index Fund
|
MF | Fidelity | 0.11% | $34,350,249.96 | 815,533 | Apr 30, 2026 | Jun 26, 2026 |
|
FIDGX
Fidelity Small Cap Growth Fund
|
MF | Fidelity | 0.39% | $33,192,244.80 | 788,040 | Apr 30, 2026 | Jun 26, 2026 |
|
JATTX
Janus Henderson Triton Fund
|
MF | Independent / Boutique | 0.63% | $32,682,901.44 | 1,100,064 | Mar 31, 2026 | May 29, 2026 |
|
VEMPX
VANGUARD EXTENDED MARKET INDEX FUND
|
ETF | Vanguard | 0.04% | $29,696,660.21 | 999,551 | Mar 31, 2026 | May 28, 2026 |
|
FBIOX
Select Biotechnology Portfolio
|
MF | Fidelity | 0.40% | $21,459,017.97 | 720,343 | Feb 28, 2026 | Apr 24, 2026 |
|
IBB
iShares Biotechnology ETF
|
ETF | BlackRock / iShares | 0.25% | $20,042,366.00 | 674,600 | Mar 31, 2026 | May 28, 2026 |
|
IWO
iShares Russell 2000 Growth ETF
|
ETF | BlackRock / iShares | 0.15% | $18,768,698.30 | 631,730 | Mar 31, 2026 | May 28, 2026 |
|
JAVTX
Janus Henderson Venture Fund
|
MF | Independent / Boutique | 0.58% | $17,898,343.85 | 602,435 | Mar 31, 2026 | May 29, 2026 |
|
FFGRX
Emerald Growth Fund
|
MF | Independent / Boutique | 1.22% | $17,112,597.84 | 406,282 | Apr 30, 2026 | Jun 22, 2026 |
|
FOCSX
Fidelity Small Cap Growth K6 Fund
|
MF | Fidelity | 0.39% | $16,902,334.80 | 401,290 | Apr 30, 2026 | Jun 26, 2026 |
|
FSPHX
Select Health Care Portfolio
|
MF | Fidelity | 0.26% | $16,384,500.00 | 550,000 | Feb 28, 2026 | Apr 24, 2026 |
|
PGRTX
SmallCap Growth Fund I
|
MF | Independent / Boutique | 0.68% | $15,947,263.80 | 378,615 | Apr 30, 2026 | Jun 25, 2026 |
|
FSMAX
Fidelity Extended Market Index Fund
|
MF | Fidelity | 0.03% | $13,951,967.76 | 468,344 | Feb 28, 2026 | Apr 24, 2026 |
|
PJP
Invesco Pharmaceuticals ETF
|
ETF | Invesco | 4.00% | $13,333,844.16 | 316,568 | Apr 30, 2026 | Jun 26, 2026 |
|
SCHA
Schwab U.S. Small-Cap ETF
|
ETF | Charles Schwab | 0.06% | $12,989,095.38 | 436,022 | Feb 28, 2026 | Apr 24, 2026 |
|
TCSEX
Nuveen Quant Small Cap Equity Fund
|
MF | TIAA / Nuveen | 0.33% | $12,927,049.20 | 306,910 | Apr 30, 2026 | Jun 24, 2026 |
|
IRGFX
Nomura Small Cap Growth Fund
|
MF | Independent / Boutique | 1.27% | $12,511,356.36 | 421,116 | Mar 31, 2026 | May 28, 2026 |
Advertisement (320x50)